Investing

Friday's Top Analyst Upgrades and Downgrades: Duke Energy, Macy's, Mosaic, Nvidia, ServiceNow, Shopify, Workday and More

FibroGen Inc. (NASDAQ: FGEN): Raymond James raised the stock to Market Perform from Underperform. Over the past 52 weeks, the shares have traded between $11.47 and $57.21, and they have a $21.57 price objective. Thursday’s last trade was reported at $11.47, which was down close to 5% for the day.

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT): The Goldman Sachs downgrade to Sell from Neutral included a price target cut to $10 from $17. That compares with the $32 consensus target and Thursday’s closing price of $13.84. The stock was down almost 7% in Friday’s premarket.

Janus International Group Inc. (NYSE: JBI): KeyBanc Capital Markets started coverage with an Overweight rating and an $18 price target. No consensus target for the building products giant was available. The stock popped almost 4% on Thursday to close at $14.45.

Leslie’s Inc. (NASDAQ: LESL): Loop Capital raised the pool supply giant’s stock to Buy from Hold and has a $25 price target. The consensus target is much higher at $33.36. The final Thursday trade came in at $21.60, or down over 3% for the day.

Macy’s Inc. (NYSE: M): JPMorgan upgraded the venerable retailer’s stock to Neutral from Underweight and also lifted the price target to $25 from $19. The consensus target is $19.15. The shares closed on Thursday at $21.61, up a stunning 20% after posting stellar earnings.

Magenta Therapeutics Inc. (NASDAQ: MGTA): Goldman Sachs resumed coverage with a Neutral rating and a $7 price target. The consensus target is up at $17.14. Thursday’s final trade came in at $6.07.


MKS Instruments Inc. (NASDAQ: MKSI): Citigroup resumed coverage with a Neutral rating and a $160 price target. The posted consensus price objective is $226.89. Thursday’s closing share price was $140.42.

Mosaic Co. (NYSE: MOS): HSBC Securities upgraded the stock to a Buy from Hold and also raised the price target to $39 from $27. The consensus target is $40.16. The stock closed on Thursday at $29.57, after pulling back almost 5% on the day.

Myovant Sciences Ltd. (NYSE: MYOV): Goldman Sachs resumed coverage with a Neutral rating and an $18 price target. The consensus target is up at $37.40. Thursday’s closing price was $21.28.

Nvidia Corp. (NASDAQ: NVDA): Benchmark resumed coverage of the semiconductor leader with a Buy rating and a $230 price target. That compares with the lower $200.56 consensus target and Thursday’s closing trade of $197.98, which was up almost 4% after the company posted stellar earnings.